Menu

Yale Prof Gets Endowed Chair Four Years After Harassment Finding

Fellow faculty members aren’t happy about it.

Aug 30, 2018
Kerry Grens

ABOVE: © ISTOCK, EDWARDOLIVE

Michael Simons, a Yale School of Medicine professor who was removed from a leadership post in 2014 after the university found him guilty of sexual harassment, was given an endowed professorship in the school’s cardiology department in July. In response, faculty members “went into an uproar,” and the school removed an online press release about Simons’s honor, Yale Daily News reported on Tuesday (August 28).

“The awarding of a new endowed chair to Dr. Simons communicates a message of tolerance: Faculty who were found guilty of sexual misconduct are still worthy of receiving this prestigious honor,” Paula Kavathas, a medical professor and former chair of the Women’s Faculty Forum at Yale, tells the college newspaper.

See “AAAS Insiders Petition to Revoke Honors of Sexual Harassers”

According to The New York Times, in 2014, a university investigation concluded that Simons had sexually harassed a postdoc at the medical school and then treated her husband, a Yale cardiologist, unfairly. Simons left his position as director of the Cardiovascular Research Center and was suspended as chief of cardiology for 18 months.

Since 2008, Simons had held a different named professorship. But the daughter of the man for whom the chair was named complained, and now another faculty member holds that seat. 

An anonymous board member of the Committee on the Status of Women in Medicine at Yale tells the student newspaper that the group “would like to see this new chair taken away.”

In an email to the New Haven Register in 2014, Simons admitted to pursuing a junior colleague, but denied other allegations.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.